iCAD (NASDAQ:ICAD) Share Price Crosses Above 200 Day Moving Average - What's Next?

iCAD, Inc. (NASDAQ:ICAD - Get Free Report) shares passed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $1.61 and traded as high as $2.06. iCAD shares last traded at $1.96, with a volume of 197,827 shares traded.

Analyst Ratings Changes

Separately, StockNews.com raised iCAD from a "sell" rating to a "hold" rating in a research report on Thursday, November 21st.

iCAD Stock Down 3.1 %

The firm has a fifty day moving average price of $1.83 and a two-hundred day moving average price of $1.61. The stock has a market capitalization of $50.43 million, a P/E ratio of -14.62 and a beta of 1.40.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in iCAD stock. Essex LLC acquired a new position in iCAD, Inc. (NASDAQ:ICAD - Free Report) in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 137,963 shares of the technology company's stock, valued at approximately $216,000. Essex LLC owned about 0.52% of iCAD as of its most recent SEC filing. Institutional investors own 24.61% of the company's stock.

iCAD Company Profile

iCAD, Inc engages in the provision of cancer detection and therapy solutions in the United States. It operates through two segments, Detection and Therapy. The company provides ProFound AI for digital breast tomosynthesis and 2D mammography; PowerLook, a density assessment solution; and ProFound Risk, a breast cancer risk analysis.